FLOWSMART™

SP²TX: Engineering the Future of Peptide Therapeutics
SP²TX: Engineering the Future of Peptide Therapeutics
SP²TX empowers the future of healthcare by developing advanced peptide synthesis technology and discovering game-changing drug candidates.
FLOWSMART™
: An innovative synthesis technology for ton-scale commercial peptide API manufacturing 
Synthesizing long complex peptides in a single run
Ipsum lauren
Synthesizing 100kg/year for a single unit system
Ipsum lauren
Fast, reliable capacity expansion
Ipsum Lauren
 Error uploading image.
Long Peptide Synthesis by FLOWSMART™
20x
Faster Synthesis
Accelerate drug trials with synthesis speeds 20 times quicker than existing methods
10x
Cost Reduction
Slash synthesis expenses by more than 10 times compared to traditional approaches
15x
Lower Entry Cost
Reduce initial investment requirements by 15 times, enabling broader access
Pioneering Precision Medicine with Advanced Peptide Therapies
Our focus lies in developing innovative peptide drug candidates designed to precisely target disease pathways and deliver highly effective treatments. We believe these cutting-edge molecules will redefine therapeutic outcomes for patients in critical need.

Noble peptides that are working 
신규개발물질 (예: OT-5) 동물실험결과 게시 (시간에 따른 체중 감량 그래프 등)
Contact SP²TX
Leave a Message​
​